L'Oréal groupe unveils new research on pigmentation and hormonal variations' impact on women's skin and scalp at World Congress of Dermatology.
05 Luglio 2023 - 8:59AM
L'Oréal groupe unveils new research on pigmentation and hormonal
variations' impact on women's skin and scalp at World Congress of
Dermatology.
Singapore, 5 th July 2023 – today at the World Congress
of Dermatology (WCD) in Singapore, L’Oréal shared its vision for
the future of dermatology by unveiling new research and innovations
for skin health. The WCD brings together the world’s leading
dermatologists, scientists and researchers to discuss the latest
advances in dermatology.
Landmark Research
L’Oréal Dermatological Beauty (LDB) unveiled the results of two
global skin health studies conducted by La Roche-Posay (LRP) and
Vichy, respectively:
- In the largest study of its kind, LRPX surveyed 48,000 people
across 34 countries and found that half (50%) suffer from
self-reported pigmentary disorders (PD) including vitiligo,
post-inflammatory hyperpigmentation and melasma. Nearly a third
(28%) reported a strong impact on quality of life as a result, and
44% of those with a PD reported hiding the visible part of their
affected skin.
- Vichy presented the findings of a survey of 20,000 women from
20 countries that showed 72% of women feel hormonal variations
negatively impact their well-being, and the majority of women (3
out of 4) say skin problems are present or worsen during menstrual
periods.
L’Oréal harnesses decades of dermatologist-validated innovation
developed by over 4,000 scientists, to deliver new products and
services that help better diagnose, prevent and address a range of
skin disorders. At WCD, L’Oréal will showcase innovations for skin
defense, photoprotection, pigmentation and ageing, underpinned by
sustainability and inclusivity.
Novel Ingredients and Green
Sciences
Mexoryl 400 is the key, patented ingredient in
UVMune 400 by La Roche-Posay, L’Oréal’s first
technology to protect skin against ultra-long UVA and
prevent skin damage caused by photoaging, photo pollution, as well
as the modification of genes that can lead to skin cancer.
Pro-Xylane by L’Oréal Paris is the first active
ingredient obtained through green science, made from natural sugars
found in beechwood. Invented more than 20 years ago, the Pro-Xylane
molecule was subsequently patented and serves as a benchmark for
L’Oréal anti-ageing solutions.
Madecassoside, found in Baume Cicaplast
B5 by La Roche-Posay, is made from
Centella Asiatica plant leaves, water and ethanol from sugar cane.
The plant extract is known for its soothing and anti-inflammatory
properties, and for helping skin healing.
“We are delighted to return to the World Congress of Dermatology
armed with new insights on global skin concerns to complement the
important work of the dermatology community,” said Barbara
Lavernos, Deputy Chief Executive Officer in charge of Research,
Innovation and Technology, L’Oréal Groupe. “Thanks to
extensive research, innovation and growing investments in tech,
together we can help address people’s most pressing skin and hair
concerns – from hyperpigmentation to sun protection, acne, dry skin
and beyond – enabling more people to enjoy healthier skin and a
greater quality of life.”
“Together with the dermatologist community, we are advancing
skin health for all people, in their infinite diversity,” said
Myriam Cohen-Welgryn, Worldwide President, L’Oréal
Dermatological Beauty Division. “By helping increase
scientific knowledge, creating new, sustainable products and
augmented services, and supporting people in need, we are helping
extend access to skin health to ever-more people around the
world.”
About L’Oréal
For over 110 years, L’Oréal, the world’s leading beauty player,
has devoted itself to one thing only: fulfilling the beauty
aspirations of consumers around the world. Our purpose, to create
the beauty that moves the world, defines our approach to beauty as
inclusive, ethical, generous and committed to social and
environmental sustainability. With our broad portfolio of 36
international brands and ambitious sustainability commitments in
our L’Oréal for the Future programme, we offer each and every
person around the world the best in terms of quality, efficacy,
safety, sincerity and responsibility, while celebrating beauty in
its infinite plurality.
With 87 400 committed employees, a balanced geographical
footprint and sales across all distribution networks (e-commerce,
mass market, department stores, pharmacies, hair salons, branded
and travel retail), in 2022 the Group generated sales amounting to
38.26 billion euros. With 20 research centers
across 11 countries around the world and a dedicated Research and
Innovation team of over 4 000 scientists and 5 500 tech and digital
professionals, L’Oréal is focused on inventing the future of beauty
and becoming a Beauty Tech powerhouse.
More information on https://www.loreal.com/en/mediaroom
Contacts L'Oréal
Individual shareholders and market
regulators
Pascale GUERIN - Tél : 01 49 64 18
89 - pascale.guerin@loreal.com
Financial analysts and institutional
investors
Françoise LAUVIN - Tél : 01 47 56 86 82
- francoise.lauvin@loreal.com
Médias
Noëlle CAMILLERI - Tél : 06 79 92 99 39
- noelle.camilleri@loreal.com
Brune DIRICQ - Tél : 06 63 85 29 87
- brune.diricq@loreal.com
Christine BURKE - Tél : 06 75 54 38 15
- christine.burke@loreal.com
- PR_L’ORÉAL GROUPE UNVEILS NEW RESEARCH ON PIGMENTATION AND
HORMONAL VARIATIONS IMPACT ON WOMEN’S SKIN AND SCALP AT WORLD
CONGRESS OF DERMATOLOGY.pdf
Grafico Azioni LOreal (BIT:OR)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni LOreal (BIT:OR)
Storico
Da Mag 2023 a Mag 2024